Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immucell (ICCC) Tax Provisions (2016 - 2025)

Immucell (ICCC) has disclosed Tax Provisions for 16 consecutive years, with $4456.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Tax Provisions rose 232.54% year-over-year to $4456.0, compared with a TTM value of $14300.0 through Sep 2025, up 166.39%, and an annual FY2024 reading of $10056.0, up 117.33% over the prior year.
  • Tax Provisions was $4456.0 for Q3 2025 at Immucell, up from $1904.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $8043.0 in Q3 2021 and bottomed at $229.0 in Q3 2023.
  • Average Tax Provisions over 5 years is $2340.3, with a median of $1510.0 recorded in 2022.
  • The sharpest move saw Tax Provisions plummeted 94.08% in 2023, then surged 485.15% in 2024.
  • Year by year, Tax Provisions stood at $1122.0 in 2021, then surged by 34.58% to $1510.0 in 2022, then dropped by 10.73% to $1348.0 in 2023, then surged by 347.77% to $6036.0 in 2024, then dropped by 26.18% to $4456.0 in 2025.
  • Business Quant data shows Tax Provisions for ICCC at $4456.0 in Q3 2025, $1904.0 in Q2 2025, and $1904.0 in Q1 2025.